Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hansa Biopharma Major Shareholding Notification 2016

Mar 8, 2016

3057_iss_2016-03-08_b1a1813d-798c-4c30-94b8-362860526e04.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Hansa Biopharma AB

Holder

Gladiator

Instrument

Instrument aktie SE0002148817
Before the transaction
Shares 1,490,000
Voting rights 1,490,000
Transaction
Reason for major shareholding notification Buy
Date 08/03/2016
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 2,490,000
Directly held voting rights 2,490,000
Indirectly held voting rights 0
Percentage
Directly held shares 7.6823 %
Directly held voting rights 7.6823 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 7.6823 % 2,490,000
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 7.6823 % 2,490,000
Group total holdings
Voting rights
2,490,000
Percentage of voting rights 7.6823
Published
08/03/2016 13:17
Contact
Name
Max Mitteregger
Phone
0854504841
Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25